Browsing Tag
Andreas Fouras
4 posts
4DMedical (ASX: 4DX) stock up 7.3% as Mayo Clinic adoption and GSK contract reset lung imaging story
Nuclear medicine VQ scans are a US$1 billion market. 4DMedical (ASX: 4DX) just landed Mayo Clinic, GSK, and Medicare. The question is now scan volume scaling speed.
May 15, 2026
4DMedical (ASX: 4DX) secures CE Mark for CT:VQ and raises A$83m to accelerate European commercial launch
4DMedical (ASX: 4DX) secures CE Mark for CT:VQ and raises A$83M to fund EU expansion. Read what this means for investors and the respiratory imaging sector.
March 27, 2026
Philips to distribute 4DMedical’s cutting-edge lung health technology across U.S.
In a monumental move set to shake up the U.S. healthcare industry, 4DMedical has just announced a comprehensive…
September 29, 2024
4DMedical expands XV LVAS scans to Detroit and Memphis imaging facilities
4DMedical Limited (ASX: 4DX), a renowned respiratory imaging technology company, has entered into agreements to deliver its XV…
November 22, 2023